Jeffrey W. Sherman

Director

Director at Larimar Therapeutics, Inc., filing insider transactions between 2025-08-28 and 2026-02-27. Also reports transactions at 1 other company.

Total Purchases

$25K

1 transaction

Total Sales

$335K

1 transaction

Companies Traded

2 total filings

Active Since

2025-08-28

Last: 2026-02-27

Companies

Larimar Therapeutics, Inc.

Xeris Biopharma Holdings, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-02-27	LRMR	Purchase	5,000	$5.00	$25K	5,000	SEC ↗
2025-08-28	XERS	Sale	42.2K	$7.92	$335K	219.2K	SEC ↗